The Wide Phenotypic Spectrum of Adult‐Onset Single Large‐Scale Mitochondrial DNA Deletion Syndromes
Journal of Inherited Metabolic Disease · 2026-11 · 49 (6)
DOI: 10.1002/jimd.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 18.11.2026. Verfasst von Kristoffer Björkman und 14 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest.
Abstract (Originalsprache)
Single large‐scale mitochondrial DNA deletions (SLSMDs) give rise to a wide spectrum of clinical features, including Kearns–Sayre syndrome (KSS) and chronic progressive external ophthalmoplegia (CPEO). Because longitudinal data are scarce, the natural history remains poorly defined. This study was undertaken to describe the clinical spectrum in a large cohort of patients with clinical onset after 16 years of age. A retrospective multicenter study was performed in patients diagnosed and followed in seven European mitochondrial disease centers. Seventy patients were included. The median age at disease onset was 27 years, and the median age at last evaluation was 52 years, with a median follow‐up duration of 19 years. Median survival from disease onset was 34 years. KSS spectrum disorder was present in 36% of the patients, while CPEO was identified in the remaining 64%. Among those with CPEO at onset, 27% progressed to KSS spectrum disorder. Multisystem involvement was present in 59%. The most frequently reported symptoms or signs were ptosis and/or ophthalmoplegia (100%), skeletal muscle weakness (56%), perceived fatigue (34%), visual impairment (30%), exercise intolerance (33%), pigmentary retinopathy (20%), hearing impairment (19%), cardiac conduction block (15%), ataxia (11%), epilepsy (14%), and cognitive impairment (11%). Our study gives further insight into the highly heterogenous clinical presentation and natural history associated with SLSMDs. The relevance of categorizing patients into classical syndromic phenotypes may be questioned, as the observed overlap in clinical manifestations and the frequent evolution of phenotype over time suggest a continuum of disease expression rather than clearly distinct syndromic entities.
Förderung
- Helse Vest
Zitieren
APA
Björkman, K., Coo, I. D., Vissing, J., Hikmat, O., Engvall, M., Lindberg, C., Majamaa, K., Østergaard, E., Isohanni, P., Uusimaa, J., Naess, K., Kollberg, G., Varhaug, K. N., Tulinius, M., & Darin, N. (2026). The Wide Phenotypic Spectrum of Adult‐Onset Single Large‐Scale Mitochondrial DNA Deletion Syndromes. Journal of Inherited Metabolic Disease, 49(6). https://doi.org/10.1002/jimd.70274
Vancouver
Björkman K, Coo ID, Vissing J, Hikmat O, Engvall M, Lindberg C, et al. The Wide Phenotypic Spectrum of Adult‐Onset Single Large‐Scale Mitochondrial DNA Deletion Syndromes. Journal of Inherited Metabolic Disease. 2026;49(6). doi:10.1002/jimd.70274
BibTeX
@article{Bjrkman2026,
author = {Björkman, Kristoffer and Coo, Irenaeus de and Vissing, John and Hikmat, Omar and Engvall, Martin and Lindberg, Christopher and Majamaa, Kari and Østergaard, Elsebet and Isohanni, Pirjo and Uusimaa, Johanna and Naess, Karin and Kollberg, Gittan and Varhaug, Kristin N. and Tulinius, Mar and Darin, Niklas},
title = {The Wide Phenotypic Spectrum of Adult‐Onset Single Large‐Scale Mitochondrial DNA Deletion Syndromes},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {6},
doi = {10.1002/jimd.70274}
}
EUVIMED